Compare LAB & ACRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LAB | ACRE |
|---|---|---|
| Founded | 1999 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Real Estate Investment Trusts |
| Sector | Industrials | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 326.2M | 261.9M |
| IPO Year | 2008 | 2011 |
| Metric | LAB | ACRE |
|---|---|---|
| Price | $0.69 | $4.57 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 4 |
| Target Price | $1.35 | ★ $5.38 |
| AVG Volume (30 Days) | ★ 1.5M | 308.7K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 11.58% |
| EPS Growth | ★ 61.54 | 26.17 |
| EPS | 0.26 | ★ 1.35 |
| Revenue | ★ $101,937,000.00 | $54,833,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.63 | $16.28 |
| P/E Ratio | ★ $2.58 | $3.36 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.63 | $4.14 |
| 52 Week High | $1.72 | $5.89 |
| Indicator | LAB | ACRE |
|---|---|---|
| Relative Strength Index (RSI) | 40.83 | 45.29 |
| Support Level | $0.63 | $4.33 |
| Resistance Level | $1.02 | $4.69 |
| Average True Range (ATR) | 0.04 | 0.11 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 47.15 | 31.51 |
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.
Ares Commercial Real Estate Corp is a specialty finance company and a real estate investment trust mainly engaged in originating and investing in commercial real estate (CRE) loans and related investments. It operates in one segment, namely originating and managing a diversified portfolio of CRE debt-related investments. The company recognizes the majority of its revenues in the form of interest income, which it receives from loans.